Guillou B, Robinet G, Gouva S, Guillodo M P, Daniel C, Clavier J
Service d'Oncologie broncho-pulmonaire, CHR Morvan, Brest.
Rev Pneumol Clin. 1998 Sep;54(4):215-8.
Optimal dosage for chemotherapy administered to patients on chronic hemodialysis remains a difficult question. We report the case of a patient with chronic renal failure on hemodialysis for 9 years who was treated for small-cell lung cancer. The chemotherapy protocol combined carboplatin and etoposide at doses adapted to creatinine clearance. Tumor regression was observed after 6 cycles without major intolerance.
